Publication date: Available online 28 August 2016
Source:Journal of Allergy and Clinical Immunology
Author(s): Mübeccel Akdis, Alar Aab, Can Altunbulakli, Kursat Azkur, Rita A. Costa, Reto Crameri, Su Duan, Thomas Eiwegger, Andrzej Eljaszewicz, Ruth Ferstl, Remo Frei, Mattia Garbani, Anna Globinska, Lena Hess, Carly Huitema, Terufumi Kubo, Zsolt Komlosi, Patricia Konieczna, Nora Kovacs, Umut C. Kucuksezer, Norbert Meyer, Hideaki Morita, Judith Olzhausen, Liam O'Mahony, Marija Pezer, Moira Prati, Ana Rebane, Claudio Rhyner, Arturo Rinaldi, Milena Sokolowska, Barbara Stanic, Kazunari Sugita, Angela Treis, Willem van de Veen, Kerstin Wanke, Marcin Wawrzyniak, Paulina Wawrzyniak, Oliver F. Wirz, Josefina Sierra Zakzuk, Cezmi A. Akdis
There have been extensive developments on cellular and molecular mechanisms of immune regulation in allergy, asthma, autoimmune diseases, tumor development, organ transplantation, and chronic infections during the last few years. Better understanding the functions, reciprocal regulation, and counterbalance of subsets of immune and inflammatory cells that interact through interleukins, interferons, TNF-α, and TGF-β offer opportunities for immune interventions and novel treatment modalities in the era of development of biological immune response modifiers particularly targeting these molecules or their receptors. More than 60 cytokines have been designated as interleukins since the initial discoveries of monocyte and lymphocyte interleukins (called IL-1 and IL-2, respectively). Studies of transgenic or gene-deficient mice with altered expression of these cytokines or their receptors and analyses of mutations and polymorphisms in human genes that encode these products have provided essential information about their functions. Here we review recent developments on IL-1 to IL-38, TNF-α, TGF-β, and interferons. We highlight recent advances during the last few years in this area and extensively discuss their cellular sources, targets, receptors, signaling pathways, and roles in immune regulation in patients with allergy and asthma and other inflammatory diseases.
from #MedicinebyAlexandrosSfakianakis via xlomafota13 on Inoreader http://ift.tt/2bKafYt
via IFTTT
Αρχειοθήκη ιστολογίου
-
►
2020
(289)
- ► Φεβρουαρίου (28)
-
►
2019
(9071)
- ► Δεκεμβρίου (19)
- ► Σεπτεμβρίου (54)
- ► Φεβρουαρίου (3642)
- ► Ιανουαρίου (3200)
-
►
2018
(39872)
- ► Δεκεμβρίου (3318)
- ► Σεπτεμβρίου (3683)
- ► Φεβρουαρίου (2693)
- ► Ιανουαρίου (3198)
-
►
2017
(41099)
- ► Δεκεμβρίου (3127)
- ► Σεπτεμβρίου (2173)
-
▼
2016
(13807)
- ► Δεκεμβρίου (700)
- ► Σεπτεμβρίου (600)
-
▼
Αυγούστου
(1550)
-
▼
Αυγ 28
(50)
- China Pharmacy, Year 2016, Issue 22 -New Issue Alert.
- Anatomy and Clinics, Year 2016, Issue 04 -New Issu...
- Journal of Brain and Nervous Diseases, Year 2016, ...
- Journal of Clinical Electroneurophysiology, Year 2...
- Journal of Clinical Transfusion and Laboratory Med...
- Journal of Clinical Neurosurgery, Year 2016, Issue...
- Journal of Snake, Year 2016, Issue 02 -New Issue A...
- Chinese Journal of Ocular Fundus Diseases, Year 20...
- Journal of Microbes and Infection, Year 2016, Issu...
- Journal of Evidence-Based Medicine, Year 2016, Iss...
- Chinese Journal of AIDS & STD, Year 2016, Issue 07...
- BacterioFiles 265 - Predator Protein Protects Pred...
- Hybrid minimally invasive Ivor Lewis esophagectomy...
- Development and implementation of a comprehensive ...
- Comment on: Contributing factors and outcomes of t...
- Isolated central nervous system primary acute mono...
- Risk-stratification management of febrile neutrope...
- PDGFRα signalling promotes fibrogenic responses in...
- Next generation TCR sequencing – a tool to underst...
- Evaluation of gastrointestinal leakage using serum...
- Morphogenetic and Molecular Analyses of Cyst Wall ...
- Validation of ultrasonography for non-invasive ass...
- Selective accumulation of biotin in arterial chemo...
- De novo Loss of function Mutations in KIAA2022 Are...
- Methane emissions measurements of natural gas comp...
- mir-22 oncosuppressor network in Rhabdomyosarcoma
- SOX9 and gastric cancer
- MSC Exosomes in Cancer Dormancy
- HPV OPSCC in the UK
- Genetic Dissection of miR-10b and Breast Cancer
- Cancer chemotherapy requires T cell costimulation
- Rapamycin promotes human and murine anti-cancer {g...
- SMYD3-methylated H2A.Z.1 up-regulates cyclin A1
- Therapeutic outcomes of MTD vs. LDM therapy regimens
- FOXD1-ALDH1A3 Axis in Mesenchymal Glioma Stem-like...
- Lung tumor angiogenesis
- EpCAM-Regulated Transcription Promotes EMT
- Alpha-synuclein RT-QuIC in the CSF of patients wit...
- Endophytic Fungi Spores
- TWiV 404: Not found
- "In Vivo"[jour]; +29 new citations
- Wee – Avoiding Disaster – Endotracheal Tube Cuff L...
- Letter to the editor referring to the publication ...
- Efficacy of photodynamic therapy combined with a g...
- Interleukins (from IL-1 to IL-38), interferons, tr...
- Efficacy of buprenorphine added to 2% lignocaine p...
- Schneider membrane thickness classification evalua...
- Bacterial Messages From Beyond?
- Six year adalimumab efficacy in steroid-dependent ...
- Schneider membrane thickness classification evalua...
-
▼
Αυγ 28
(50)
- ► Φεβρουαρίου (1350)
- ► Ιανουαρίου (1400)
-
►
2015
(1500)
- ► Δεκεμβρίου (1450)
Ετικέτες
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου